We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
CYN | CYNGN Inc | 0.2166 | 0.0956 | 79.01% | 174,996,515 |
OPRT | Oportun Financial Corporation | 3.15 | 0.90 | 40.00% | 4,854,508 |
PALI | Palisade Bio Inc | 6.8563 | 1.93 | 39.07% | 17,156,787 |
PEGY | Pineapple Energy Inc | 0.0631 | 0.0173 | 37.77% | 113,175,973 |
JFU | 9F Inc | 3.435 | 0.725 | 26.75% | 32,581 |
NIVF | NewGenIvf Group Ltd | 1.58 | 0.30 | 23.44% | 10,136,184 |
SMFL | Smart for Life Inc | 5.355 | 1.01 | 23.10% | 11,507,879 |
HWH | HWH International Inc | 1.56 | 0.28 | 21.88% | 13,657,795 |
LGHLW | Lion Group Holding Ltd | 0.0068 | 0.0012 | 21.43% | 2,616 |
HIBB | Hibbett Inc | 86.115 | 13.63 | 18.80% | 1,401,091 |
NKGN | NKGen Biotech Inc | 1.73 | 0.26 | 17.69% | 6,232,086 |
MENLO PARK, Calif., April 23, 2024 /PRNewswire/ -- Cyngn Inc. ("Cyngn", NASDAQ: CYN) has been chosen to supply its DriveMod Tuggers for industrial automation to John Deere's operation in Dubuque, Iowa. Cyngn is a supplier of AI-powered autonomous vehicle and data solutions based in Menlo Park, CA.
Company has improved its balance sheet by $27 million over the past 90 days Chairman and CEO has converted all $17.22 million of his debt into equity Company bolsters balance sheet with $5.25 million capital infusion CHESAPEAKE, Va., April 23, 2024 /PRNewswire/ -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (Nasdaq: GWAV), a leading operator of metal recycling facilities in Virginia, North Carolina, and Ohio, announced today that on April 22, 2024, it further strengthened its balance sheet by approximately $12 million.
Hibbett, Inc. (“Hibbett”) (Nasdaq:HIBB), an athletic-inspired fashion retailer, today announced a definitive agreement in which JD Sports Fashion plc (“JD Sports”) (LSE:JD) will acquire all outstanding shares of Hibbett for $87.50 per share in cash, representing an aggregate enterprise value of approximately $1.1 billion.
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that recently reported twelve-month follow-up data from its Phase 2a trial of Descartes-08 in patients with generalized myasthenia gravis will be featured during an oral presentation at the upcoming American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting being held May 7-11, 2024 in Baltimore, MD. Descartes-08, the Company’s lead product candidate, is an autologous anti-B cell maturation antigen (BCMA) mRNA-engineered chimeric antigen receptor T-cell therapy (mRNA CAR-T).
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,950.00 | 92.05 | 0.14% | 1.31T | 3,451,712,242 |
ETH | Ethereum | 3,247.66 | 45.60 | 1.42% | 388.91B | 1,572,269,834 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 391,101,772 |
BNB | Binance Coin | 607.77 | 2.67 | 0.44% | 96.06B | 411,164,854 |
SOL | Solana | 157.92 | 0.910 | 0.58% | 69.43B | 1,046,903,934 |
STETH | stETH | 3,244.15 | 43.69 | 1.37% | 31.75B | 3,223,223 |
XRP | Ripple | 0.5483 | -0.0083 | -1.49% | 29.87B | 458,317,892 |
USDC | USD Coin | 0.9998 | -0.0002 | -0.02% | 28.07B | 1,117,392,694 |
DOGE | Dogecoin | 0.16142 | 0.00019 | 0.12% | 23.04B | 354,675,621 |
TONCOIN | Wrapped TON Coin | 5.70 | -0.210838 | -3.57% | 19.73B | 150,344,972 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions